OPPORTUNITIES FOR EARLY OUTPATIENT DIAGNOSTICS OF OBSTRUCTIVE SLEEP DISORDERED BREATHING

Aim. To evaluate the prevalence of possible obstructive respiratory disorder during sleep in outpatients by the data from computed monitoring pulse oxymetry (CPO) and questionnaires.

Material and methods. To the open one stage non-randomized comparative study, 175 patients included: 37,1% males, 62,9% females, age 55,1±11,1 y.o., visiting a clinician office at outpatient facility. Sleep disordered breathing of obstructive origin was diagnosed with a survey, modified Stradling questionnaire and CPO; and excessive daytime sleepiness — with Epworth score. For confirmation of obstructive sleep apnea (OSA), a bifunctional monitoring was performed (BM) with further comparison of the data with CPO results.

Results. Chronic hypoxemia at night by CPO was found in 71,4% patients, and probability of OSA moderate and severe — in 42,8% patients. By the modified Stradling, OSA was predicted in 57,7%, by Epworth, the daytime sleepiness was found in 11,4%. Mild OSA in BM was found in 8,9%, moderate — 14,7%, severe — 20,6%. The data from CPO matched with BM in 80% patients. Sensitivity of CPO for nocturnal hypoxemia of various severity was 92,4%, specificity — 76,4%; sensitivity of the Stradling questionnaire — 88,9%, specificity — 88,2%. Sensitivity of Epworth score — 27,8%, specificity — 82,4%.

Conclusion. Chronic nocturnal hypoxemia was found in 71,4%, and probability of moderate and severe OSA — in 42,8% in outpatients with internal diseases profile. CPO and Stradling questionnaire can be applied as diagnostic instruments for OSA at outpatient stage.

1. Pinto J, Ribeiro D, Cavallini A, et al. Comorbidities Associated with Obstructive Sleep Apnea: a Retrospective Study. International Archives of Otorhinolaryngology 2016; 20 (2): 145-50. DOI: 10.1055/s-0036-1579546.

2. Zhang L, Hou Y, Po S. Obstructive Sleep Apnoea and Atrial Fibrillation. Arrhythmia and electrophysiology review 2015; 4 (1): 14-8. DOI: 10.15420/aer.2015.4.1.14.

3. Sforza E, Hupin D, Pichot V, et al. A 7-year follow-up study of obstructive sleep apnoea in healthy elderly: The PROOF cohort study. Respirology 2017; 22 (5): 1007-14. DOI: 10.1111/resp.13013.

4. Peppard PE, Young T, Barnet JH, et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013; 177 (9): 1006-14. DOI: 10.1093/aje/kws342.

5. Piepoli M, Hoes A, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016; 37: 2315-81. DOI: 10.1093/eurheartj/ehw106.

6. Wu W, Tsai S, Shih T, et al. The Association between Obstructive Sleep Apnea and Metabolic Markers and Lipid Profiles. PLoSONE 2013; 10 (6): e0130279. DOI: 10.1371/journal.pone.0130279/.

7. McNicholas W. Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am J Respirat Critic Care Med 2009; 180 (8): 692-700. DOI: 10.1164/rccm.200903- 0347PP.

8. Xie C, Zhu R, Tian Y, et al. Association of obstructive sleep apnoea with the risk of vascular outcomes and all-cause mortality: a meta-analysis. BMJ Open 2017; 7 (12): e013983. DOI: 10.1136/bmjopen-2016-013983.

9. Litvin AYu, Chazova IE, Danilov NM, Elfimova EM. RU 2412644 C1 MPK A61V 5/00 (2006.01). Method for determination of indications for polysomnography in patients with obstructive sleep apnea syndrome. Patent holder: FSU Russian Cardiology Scientific and Clinical Complex of Federal Agency of high-tech medical care. № 2009136052/14; 29.09.2009; publ. 27.02.2011, byul. № 6. (In Russ.)

10. Anttalainen U, Tenhunen M, Rimpilä V, et al. Prolonged partial upper airway obstruction during sleep — an underdiagnosed phenotype of sleep-disordered breathing. Eur Clinic Respir J 2016; 3: 31806. DOI: 10.3402/ecrj.v3.31806.

11. Oster M, Kuo K, Mahle W. Quality Improvement in Screening for Critical Congenital Heart Disease. The Journal of Pediatrics 2014; 164 (1): 67-71. DOI: 10.1016/j. jpeds.2013.08.044.

12. Chung Y, Garden F, Jee A, et al. Supine awake oximetry as a screening tool for daytime hypercapnia in super-obese patients. Internal Med J 2017; 47 (10): 1136-41. DOI: 10.1111/imj.13496.

13. Aksenova AV, Elfimova EM, Galicin PV, et al. The value of computer pulse oximetry in the practice of a cardiologist. Systemic hypertension 2014; 4 (11): 26-30. (In Russ.) Аксенова А. В., Елфимова Е. М., Галицин П. В. и др. Значение компьютерной пульсоксиметрии в практике врача-кардиолога. Системные гипертензии 2014; 4 (11): 26-30.

14. Bonzelaar L, Salapatas A, Yang J, et al. Validity of the Epworth sleepiness scale as a screening tool for obstructive sleep apnea. Laryngoscope 2017; 127 (2): 525-31. DOI: 10.1002/lary.26206.

15. Chen R, Xiong K, Lian Y, et al. Daytime sleepiness and its determining factors in Chinese obstructive sleep apnea patients. Sleep and Breathing 2011; 15 (1): 129-35. DOI: 10.1007/s11325-010-0337-4.